⌕
Neogenomics · NEO · Nasdaq
Tenet 37 · Weak
Compare
$15.25−1.04%At closeTenet 37 · Weak
$15.25−0.16 (−1.04%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Neogenomics (NEO) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Business WireNov 13, 2026 · 09:00 ET
Better Adds $43.7 Million in Volume Across Two Purchase-Focused Teams in California and the Mid-Atlantic Through NEO Home Loans Channel

NEW YORK--(BUSINESS WIRE)---- $BETR #BETR--Better Home & Finance Holding Company (NASDAQ: BETR) today announced that two established mortgage teams have joined NEO Home Loans, powered by Better. The Daniel Estrada Team i…

● Business WireNov 6, 2026 · 07:05 ETCOMPANY'S OWN WORDS
NeoGenomics to Participate in Upcoming Investor Conferences

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in the Stephens Annual Investment Conference and the Piper Sandler 38th Annual Healthcare Conference.…

● PRNewsWireOct 29, 2026 · 17:30 ETEARNINGS EXPECTED BY FEB 22
NEO Battery Reports Fiscal Year 2027 Second Quarter Results

TORONTO, Oct. 29, 2026 /PRNewswire/ -- NEO Battery Materials Ltd. ("NEO" or the "Company") (TSXV: NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery manufacturer enabling high-performance capabilities for drones, ro…

● MarketBeatOct 29, 2026 · 01:04 ETEARNINGS EXPECTED BY FEB 22
What NeoGenomics (NEO) Said on Its Q3 Earnings Call

NeoGenomics NASDAQ: NEO reported third-quarter revenue growth of 11% year over year, led by continued expansion in next-generation sequencing, or NGS, testing, while raising its full-year revenue and adjusted EBITDA guid…

● Business WireOct 28, 2026 · 16:05 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 22
NeoGenomics Reports Third Quarter 2026 Results

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced its third-quarter results for the period ended September 30, 2026.…

● Business WireOct 15, 2026 · 07:05 ET
NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics expanded its partnership with Indica Labs to scale AI-powered digital pathology and support more timely, consistent diagnostic insights.…

● GuruFocusOct 14, 2026 · 08:00 ETEARNINGS EXPECTED BY FEB 22
NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its thi…

● BenzingaOct 6, 2026 · 13:54 ETEARNINGS EXPECTED BY FEB 22
What's Going On With NeoGenomics Stock Tuesday?

Precision medicine and oncology diagnostics provider NeoGenomics Inc. (NASDAQ:NEO) on Monday announced an executive succession plan and preliminary third-quarter financial results for the period ended Sept. 30, 2026.…

● Defense WorldOct 6, 2026 · 09:40 ET
NeoGenomics (NASDAQ:NEO) Hits New 12-Month High After Analyst Upgrade

NeoGenomics, Inc. (NASDAQ: NEO - Get Free Report)'s stock price reached a new 52-week high during trading on Tuesday after Needham and Company LLC raised their price target on the stock from $19.00 to $22.00. Needham and…

● Business WireOct 5, 2026 · 16:05 ET
NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics today announced its executive leadership and board of directors succession plan.…

● Defense WorldSep 26, 2026 · 04:16 ETEARNINGS EXPECTED BY FEB 22
Omada Health (NASDAQ:OMDA) and NeoGenomics (NASDAQ:NEO) Head-To-Head Contrast

NeoGenomics (NASDAQ: NEO - Get Free Report) and Omada Health (NASDAQ: OMDA - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of…

● Defense WorldSep 21, 2026 · 06:03 ET
NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference

NeoGenomics (NASDAQ: NEO) executives outlined the company's strategy to expand its role in community-based precision oncology, emphasizing growth in next-generation sequencing, minimal residual disease testing and workfl…

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 22. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

NVDA31−0.4%
WDAY4−5.8%
BBW3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just NEO · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.